Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024

Rhea-AI Summary

Bristol Myers Squibb (NYSE: BMY) will release its second quarter 2024 financial results on July 26, 2024. The company's executives will provide an overview of the financial outcomes and answer questions from investors and analysts during a conference call scheduled for 8:00 a.m. ET on the same day.

The live conference call can be accessed through a webcast available on the company’s investor relations website. For those who cannot register for the webcast, dial-in options are available for both U.S. and international participants. Conference materials will be provided on the investor relations website before the call begins. A replay of the webcast and the conference call will be accessible post-event.

Positive

• Anticipated detailed financial results release for Q2 2024.
• Availability of live webcast and replay options for broader investor engagement.

Negative

• None.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2024 on Friday, July 26, 2024. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Investors and the public can register for the live conference call here. Those unable to register can access the live conference call by dialing in the U.S. toll free 1-833-816-1116 or international +1 412-317-0705. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.

A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on July 26, 2024, through 11:30 a.m. ET on August 9, 2024, by dialing in the U.S. toll free 1-877-344-7529 or international +1 412-317-0088, conference code: 2169814.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20240620721189/en/

Media:

media@bms.com

Investors:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When will Bristol Myers Squibb release its Q2 2024 financial results?

Bristol Myers Squibb will release its second quarter 2024 financial results on July 26, 2024.

What time is the Bristol Myers Squibb Q2 2024 earnings call?

The Bristol Myers Squibb Q2 2024 earnings call will begin at 8:00 a.m. ET on July 26, 2024.

How can I listen to the Bristol Myers Squibb Q2 2024 earnings call?

You can listen to the live webcast at http://investor.bms.com or dial in using U.S. toll free 1-833-816-1116 or international +1 412-317-0705.

Where can I find the materials related to the Bristol Myers Squibb Q2 2024 earnings call?

Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.

Will there be a replay available for the Bristol Myers Squibb Q2 2024 earnings call?

Yes, a replay of the webcast will be available at http://investor.bms.com approximately three hours after the call concludes, and a conference call replay will be available until August 9, 2024.